Infusion of tiny mitochondria helps rejuvenate tissues, so researchers hope the technique could treat a variety of damaged organs.

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

US FDA grants fast track designation to Revalesio’s lead investigational therapy, RNS60 to treat acute ischemic stroke: Tacoma, Washington Saturday, August 2, 2025, 15:00 Hrs [I ...

A sold-out audience of more than 500 people filled the auditorium last night for the Sixth Annual Morning Pointe Seniors Got ...

Your mouth serves as a gateway to your entire body, harboring millions of bacteria that can either support your health or ...

Donanemab, approved by the FDA in 2024 to treat Alzheimer's disease, is a monoclonal antibody directed at N-terminally ...

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires ...

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel ...

Exercise-based cardiac rehabilitation reduces recurrence, severity, and burden of atrial fibrillation, while improving mental ...

A groundbreaking study from the University of Cambridge reveals a new drug that can significantly reduce brain damage caused ...

You may have heard the phrase "my heart skipped a beat" when someone was talking about a romantic encounter. In truth, hearts ...